Frequency of Three-Vessel Disease Among Patients With Non-ST Segment Elevation Myocardial Infarction

Faisal Ahmed1, Muhammad Sami Khan2, Syed Dilbahar Ali Shah1

  • 1Cardiology, Dow University of Health Sciences, Civil Hospital Karachi, Karachi, PAK.

Cureus
|December 31, 2020
PubMed

Insights

Three-vessel disease (3VD) affects nearly a third of non-ST Segment Elevation Myocardial Infarction (NSTEMI) patients. Diabetes Mellitus significantly increases the risk of 3VD in NSTEMI patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Three-vessel disease (3VD) is a common finding in patients with non-ST Segment Elevation Myocardial Infarction (NSTEMI).
  • Limited data exists on the clinical significance and frequency of 3VD in NSTEMI patients, particularly in South Asia.
  • This study investigates the prevalence of 3VD in NSTEMI patients at a tertiary care hospital in Karachi, Pakistan.

Purpose of the Study:

  • To determine the frequency of three-vessel disease (3VD) in patients diagnosed with non-ST Segment Elevation Myocardial Infarction (NSTEMI).
  • To analyze the association of comorbidities, particularly diabetes mellitus, with the presence of 3VD in NSTEMI patients.
  • To assess the impact of demographic factors like age and gender on the occurrence of 3VD in this patient cohort.

Main Methods:

  • A cross-sectional study involving 139 NSTEMI patients was conducted at the National Institute of Cardiovascular Diseases, Karachi.
  • Data on patient demographics and comorbidities were collected, and coronary angiography was performed to diagnose 3VD.
  • Statistical analysis, including SPSS version 20.0, was used to analyze the frequency of 3VD and occluded arteries.

Main Results:

  • The overall frequency of 3VD among NSTEMI patients was 30.2%.
  • The most commonly occluded arteries were the left anterior descending (LAD) and right coronary artery (RCA).
  • Diabetes Mellitus was found to be a significant comorbidity associated with 3VD in NSTEMI patients (p < 0.05).

Conclusions:

  • A significant proportion of NSTEMI patients present with three-vessel disease.
  • The presence of 3VD in NSTEMI patients is independent of age and gender.
  • Diabetes Mellitus is a key risk factor for 3VD in the context of NSTEMI.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
95
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
167
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.3K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
80
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
307
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
140